Work

354a: ONGOING PHASE 1B/2 TRIAL OF THE ALLOSTERIC MEK1/2 INHIBITOR REC-4881 AS MONOTHERAPY IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP): PRELIMINARY SAFETY AND EFFICACY DATA

Year: 2025

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(25)05718-x

Authors: N. Jewel Samadder, Gautam N. Mankaney, Jessica Stout, Reid M. Ness, Ziad H. Younes, Harinath Sheela, Bryson W. Katona, Bahar Shamloo, Kasara Yousefi, Johnny Viscusi, Ying Su

Language: English

Topic: Genetic factors in colorectal cancer

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411999603

FWCI:

Cites:

Cited by:

Related to: 10